ArticleNature communications2022
Strikingly distinctive NH
Article in Nature communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Yolk-shell zeolite nanoreactors enable multi-poison resistance for NONature communications · 2026Article
- Insights into the mechanisms of NHNature communications · 2026Article
- Coaxial 3D printing of zeolite core-shell structured catalysts for integrated NOChemical science · 2026Article
- Review
- Effect of SOACS engineering Au · 2024Article
- Thermally stable high-loading single Cu sites on ZSM-5 for selective catalytic oxidation of NHProceedings of the National Academy of Sciences of the United States of America · 2024Article
- Unlocking the Potential of Metal-Doping FeACS omega · 2024Article
- Effects of Si/Al Ratio on Passive NOMolecules (Basel, Switzerland) · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Commercial Cu-exchanged small-pore SSZ-13 (Cu-SSZ-13) zeolite catalysts are highly active for the standard selective catalytic reduction (SCR) of NO with NH
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.